Skip to content

Effects of the Buxue Yimu Pill on pregnant results among women in a frozen embryo transfer cycle

Effects of the Buxue Yimu Pill on pregnant results among women in a frozen embryo transfer cycle

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090995
Enrollment
Unknown
Registered
2024-10-17
Start date
2024-01-08
Completion date
Unknown
Last updated
2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Observation group:Buxue Yimu Pill+hormone replacement cycle endometrial preparation program
Control group:Hormone replacement cycle endometrial preparation program

Sponsors

Zigong Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Infertile women who have undergone IVF assisted pregnancy in our department and have indications for IVF, excluding contraindications, are planned to undergo resuscitation transplantation in our department; Age<40 years old Normal liver and kidney function; BMI between 18-24kg/m2 No other endocrine related diseases, no history of endocrine related tumors; High score blastocyst with D5 score = 3AA, 3AB, 3BA, 3BB or D6 score = 4AA, 4AB, 4BA, 4BB; = 1 high score blastocyst transfer

Exclusion criteria

Exclusion criteria: Reproductive system malformations and organic lesions: such as severe uterine malformations or a history of multiple intrauterine adhesions; Presence of uterine polyps, uterine fluid accumulation, fallopian tube fluid accumulation, etc; There is a reproductive system infection; Either spouse has chromosomal abnormalities, or has a history of consanguineous marriage or family genetic diseases; Severe endocrine disorders, history of thrombotic diseases, malignant tumors, cardiovascular and cerebrovascular diseases, autoimmune diseases; Abnormal semen routine of the male partner; Long term smoking patients.

Design outcomes

Primary

MeasureTime frame
Clinical pregnancy rate;

Secondary

MeasureTime frame
Biochemical pregnancy rate;Ulterine artery blood flow index;Estradiol value on embryo-transfer;Endometrium thickness;

Countries

China

Contacts

Public ContactHao Li

Zigong Maternal and Child Health Hospital

hl756756@163.com+86 173 9056 5633

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026